StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.11−1.13 (-5.58%)

Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%

Nuvectis Pharma total assets

Total assets on the balance sheet at the end of each period.

Nuvectis Pharma's total assets was $22.38M at Jun 30, 2026. For fiscal 2025 it was $31.71M, up 70.4% from the year before. The highest annual figure on record is $31.71M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.71M+70.4%
FY2024Dec 31, 2024$18.61M-3.0%
FY2023Dec 31, 2023$19.19M-6.0%
FY2022Dec 31, 2022$20.41M+206.5%
FY2021Dec 31, 2021$6.66M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.38M-17.1%
Q1 FY2026Mar 31, 2026$25.40M-15.8%
Q4 FY2025Dec 31, 2025$31.71M+70.4%
Q3 FY2025Sep 30, 2025$35.59M+105.6%
Q2 FY2025Jun 30, 2025$27.01M+47.6%
Q1 FY2025Mar 31, 2025$30.15M+52.9%
Q4 FY2024Dec 31, 2024$18.61M-3.0%
Q3 FY2024Sep 30, 2024$17.31M-22.3%
Q2 FY2024Jun 30, 2024$18.30M-26.6%
Q1 FY2024Mar 31, 2024$19.71M+21.6%
Q4 FY2023Dec 31, 2023$19.19M-6.0%
Q3 FY2023Sep 30, 2023$22.26M-10.5%
Q2 FY2023Jun 30, 2023$24.94M+75.2%
Q1 FY2023Mar 31, 2023$16.21M-8.0%
Q4 FY2022Dec 31, 2022$20.41M+206.5%
Q3 FY2022Sep 30, 2022$24.87M–
Q2 FY2022Jun 30, 2022$14.24M–
Q1 FY2022Mar 31, 2022$17.62M–
Q4 FY2021Dec 31, 2021$6.66M–

More Nuvectis Pharma figures

See a number that looks wrong?